{"altmetric_id":3574729,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:19151720"],"posts_count":1}},"citation":{"abstract":"It is well described in the urological literature that androgen deprivation can result in accelerated bone breakdown and osteoporosis. Therefore, we evaluate the degree of bone breakdown in patients on conventional androgen deprivation with those on diethylstilbesterol alone or in conjunction with luteinizing hormone releasing hormone agonists or orchiectomy.","abstract_source":"pubmed","altmetric_jid":"4f6fa62b3cf058f610007f12","authors":["Douglas Scherr","W Reid Pitts","E Darracott Vaughn"],"first_seen_on":"2015-02-13T04:29:48+00:00","handles":[],"isbns":[],"issns":["0022-5347"],"issue":"2 Pt 1","journal":"The Journal of Urology","last_mentioned_on":1254145012,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11792913"],"pmid":"11792913","pubdate":"2002-02-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"Diethylstilbesterol revisited: androgen deprivation, osteoporosis and prostate cancer.","type":"article","volume":"167","mendeley_url":"http:\/\/www.mendeley.com\/research\/diethylstilbesterol-revisited-androgen-deprivation-osteoporosis-prostate-cancer"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3628496,"mean":4.94108381299,"rank":817044,"this_scored_higher_than_pct":63,"this_scored_higher_than":2288470,"rank_type":"exact","sample_size":3628496,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":95205,"mean":8.2073660770557,"rank":24749,"this_scored_higher_than_pct":72,"this_scored_higher_than":69380,"rank_type":"exact","sample_size":95205,"percentile":72},"this_journal":{"total_number_of_other_articles":4244,"mean":2.5650747112892,"rank":708,"this_scored_higher_than_pct":71,"this_scored_higher_than":3030,"rank_type":"exact","sample_size":4244,"percentile":71},"similar_age_this_journal_3m":{"total_number_of_other_articles":31,"mean":1.8416666666667,"rank":3,"this_scored_higher_than_pct":90,"this_scored_higher_than":28,"rank_type":"exact","sample_size":31,"percentile":90}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Librarian":1,"Researcher":1,"Student  > Ph. D. Student":1,"Other":1,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":7}}}},"posts":{"wikipedia":[{"title":"Douglas Scherr","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=316679098#altmetric_citation_30","license":"public","citation_ids":[3574724,3574729],"posted_on":"2009-09-28T13:36:52+00:00","summary":"Douglas S. Scherr, M.D. (born January 7, 1967) is an American surgeon and specialist in Urologic Oncology.","page_url":"http:\/\/en.wikipedia.org\/?curid=19151720","wiki_lang":"en","author":{"name":"Chris Capoccia","url":"http:\/\/en.wikipedia.org\/wiki\/User:Chris Capoccia"}}]}}